Form 4: Predictive Oncology Director Receives Stock Grant
Insider Transaction (Form 4)
Matthew Hawryluk, a Director of Predictive Oncology Inc., received 733 shares of common stock on October 1, 2026.
Summary
- Grant/award: acquired 733 Common Stock on October 1, 2026; holds 14,176 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Matthew Hawryluk — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Common Stock | 733 | — | — | 14,176 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (733 shares) |
Keywords
insider transaction, Form 4, AGPU, Axe Compute Inc., neutral, Matthew Hawryluk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.